Literature DB >> 4621734

Endotracheal gentamicin in bronchial infections in patients with tracheostomy.

J Klastersky, C Geuning, E Mouawad, D Daneau.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4621734     DOI: 10.1378/chest.61.2.117

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  17 in total

Review 1.  Systemic and endotracheal antibiotic prophylaxis of nosocomial pneumonia in ICU.

Authors:  H Lode; G Höffken; B Kemmerich; T Schaberg
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

Review 2.  Aerosolised antibacterials for the prevention and treatment of hospital-acquired pneumonia.

Authors:  G Christopher Wood; Joseph M Swanson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 3.  Drug monitoring in nonconventional biological fluids and matrices.

Authors:  S Pichini; I Altieri; P Zuccaro; R Pacifici
Journal:  Clin Pharmacokinet       Date:  1996-03       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics of aminoglycoside antibiotics.

Authors:  J C Pechere; R Dugal
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

Review 5.  Nosocomial pneumonia in patients in intensive care units.

Authors:  S D Podnos; G B Toews; A K Pierce
Journal:  West J Med       Date:  1985-11

6.  Elevated tobramycin concentrations following endotracheal administration in a premature infant.

Authors:  Amanda Howard-Thompson; Michael L Christensen
Journal:  J Pediatr Pharmacol Ther       Date:  2008-04

7.  Antibiotic penetration into lung tissues.

Authors:  D Honeybourne
Journal:  Thorax       Date:  1994-02       Impact factor: 9.139

8.  Oropharyngeal flora as a source of bacteria colonizing the lower airways in patients on artificial ventilation.

Authors:  R van Uffelen; H K van Saene; V Fidler; A Löwenberg
Journal:  Intensive Care Med       Date:  1984       Impact factor: 17.440

9.  Systemic absorption of endotracheally administered aminoglycosides in seriously ill patients with pneumonia.

Authors:  S S Crosby; W A Edwards; C Brennan; E P Dellinger; L A Bauer
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

Review 10.  Inhaled therapeutics for prevention and treatment of pneumonia.

Authors:  Amar Safdar; Samuel A Shelburne; Scott E Evans; Burton F Dickey
Journal:  Expert Opin Drug Saf       Date:  2009-07       Impact factor: 4.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.